16 October 2018
LNC Therapeutics acquires exclusive license for the Christensenella patent from Cornell University
LNC aims to develop the first Christensenella-based drug candidate for the treatment of obesity and metabolic disorders
All
10 October 2018
Seventure Partners Responsible Investment Annual Report is available online
Click to upload our Responsible Investment Report
4 October 2018
Vedanta Biosciences Announces Successful Phase 1a/1b Data Demonstrating Safety, Tolerability, and Proof of Mechanism for Lead, Rationally Defined Bacterial Consortium Product Candidate, VE303
Vedanta Biosciences, a clinical-stage company developing a new category of therapies for immune-mediated diseases based on rationally defined consortia of human...
1 October 2018
LNC Therapeutics launches a new clinical trial, OBEMINALE 2, and treats its first patient
LNC Therapeutics, a French biotech company specialized in the gut microbiome-based drug discovery,has announced the launch of a new clinical trial with Stablor®, OBEMINALE 2,...
12 September 2018
Launchmetrics raises $50M to continue its rapid growth
The leading marketing platform and analytics solution for the Fashion, Luxury and Cosmetic (FLC) industries, aims at growing from $25m to $100m in revenue over the next 4...
25 July 2018
Safer liver resection: Perioperative assessment of liver function with the LiMAx® test shortens hospital stay and reduces complications after liver surgery
Clinical phase III trial at 6 specialized liver centers demonstrates impressive benefits of the LiMAx® test.
11 July 2018
Seventure Partners invests in Mdoloris Medical Systems
French Connected Health Startup Mdoloris Medical Systems Announces a €9m Series B
4 July 2018
Seventure Partners invests in IZICAP
IZICAP is the creator of a SaaS platform to collect, analyze and monetize payment data for local stores.
12 June 2018
INTENTO DESIGN cooperates with STMICROELECTRONICS to accelerate analog design and migration of FD-SOI chips at functional level
Intento Design has announced its collaboration with STMicroelectronics (ST) in pushing forward its ID-XploreTM EDA software aimed to solve the critical design challenges in the...
30 April 2018
Seventure Partners invests in A-Mansia
A-Mansia Biotech S.A., a belgian microbiome company, announces a €13 million first close of its Series A financing, led by Seventure Partners.